The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts
Open accessAbstract
TRANCE (tumor necrosis factor–related activation-induced cytokine) is a recently described member of the tumor necrosis factor superfamily that stimulates dendritic cell survival and has also been found to induce osteoclastic differentiation from hemopoietic precursors. However, its effects on mature osteoclasts have not been defined. It has long been recognized that stimulation of osteoclasts by agents such as parathyroid hormone (PTH) occurs through a hormonal interaction with osteoblastic cells, which are thereby induced to activate osteoclasts. To determine whether TRANCE accounts for this activity, we tested its effects on mature osteoclasts. TRANCE rapidly induced a dramatic change in osteoclast motility and spreading and inhibited apoptosis. In populations of osteoclasts that were unresponsive to PTH, TRANCE caused activation of bone resorption equivalent to that induced by PTH in the presence of osteoblastic cells. Moreover, osteoblast-mediated stimulation of bone resorption was abrogated by soluble TRANCE receptor and by the soluble decoy receptor osteoprotegerin (OPG), and stimulation of isolated osteoclasts by TRANCE was neutralized by OPG. Thus, TRANCE expression by osteoblasts appears to be both necessary and sufficient for hormone-mediated activation of mature osteoclasts, and TRANCE-R is likely to be a receptor for signal transduction for activation of the osteoclast and its survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Self-citationModulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H.-L., Steinman, R. M., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2075 · Cited by 853
Self-citationHistochemical Demonstration of Acid Phosphatases With Naphthol AS-Phosphates
(1958) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/21.3.523 · Cited by 498
CHAMBERS, T. J., McSHEEHY, P. M. J., THOMSON, B. M., & FULLER, K. (1985) · Endocrinology · doi:10.1210/endo-116-1-234 · Cited by 422
Self-citationBisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni, M., Guenther, H. L., Fleisch, H., Collin, P., & Martin, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116422 · Cited by 412
Osteoblastic Cells Mediate Osteoclastic Responsiveness to Parathyroid Hormone*
McSHEEHY, P. M. J., & CHAMBERS, T. J. (1986) · Endocrinology · doi:10.1210/endo-118-2-824 · Cited by 407
Self-citationStüber, E., Neurath, M., Calderhead, D., Perry Fell, H., & Strober, W. (1995) · Immunity · doi:10.1016/1074-7613(95)90031-4 · Cited by 390
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
Thomson, B. M., Saklatvala, J., & Chambers, T. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.104 · Cited by 387
Self-citationFuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R., & Chambers, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1733 · Cited by 362
Self-citationMcSHEEHY, P. M. J., & CHAMBERS, T. J. (1986) · Endocrinology · doi:10.1210/endo-119-4-1654 · Cited by 310
Self-citationCD40 preferentially costimulates activation of CD4+ T lymphocytes.
Cayabyab, M., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1523 · Cited by 241
Pollok, K. E., Kim, Y., Hurtado, J., Zhou, Z., Kim, K. K., & Kwon, B. S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240215 · Cited by 218
The cloning of CD70 and its identification as the ligand for CD27.
Bowman, M., Crimmins, M. A. V., Yetz-Aldape, J., Kriz, R., Kelleher, K. S., & Herrmann, S. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1756 · Cited by 140
A family of ligands for the TNF receptor superfamily
Cosman, D. J. (1994) · Stem Cells · doi:10.1002/stem.5530120501 · Cited by 126
Gruss, H. J. (1996) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592977 · Cited by 121
Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts
Chambers, T. J., Athanasou, N. A., & Fuller, K. (1984) · Journal of Endocrinology · doi:10.1677/joe.0.1020281 · Cited by 113
Self-citationOsteoblasts release osteoclasts from calcitonin-induced quiescence
Chambers, T. J. (1982) · Journal of Cell Science · doi:10.1242/jcs.57.1.247 · Cited by 111
Self-citationKodama, H., Yamasaki, A., Abe, M., Niida, S., Hakeda, Y., & Kawashima, H. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080107 · Cited by 82
Yao, G., Sun, B., Hammond, E. E., Spencer, E. N., Horowitz, M. C., Insogna, K. L., & Weir, E. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4119 · Cited by 77
Fuller, K., Gallagher, A. C., & Chambers, T. J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81382-8 · Cited by 52
Self-citationPerry, H. M., Skogen, W. F., Chappel, J. C., Kahn, A., Wilner, G. D., & Teitelbaum, S. L. (1989) · Endocrinology · doi:10.1210/endo-125-4-2075 · Cited by 45
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
Metadata
- Authors
- Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-09-07
- Volume
- 188
- Issue
- 5
- Pages
- 997-1001
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2124036292
- Cited by
- 561
- References
- 26
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.